Targeted Therapies in Oncology

2nd Edition

Giuseppe Giaccone, Jean-Charles Soria

CRC Press
July 31, 2019 Forthcoming
Reference - 498 Pages
ISBN 9780367379360 - CAT# K449450

For Instructors Request Inspection Copy

was $74.95


SAVE ~$14.99

Add to Wish List
FREE Standard Shipping!


Since the last edition of this book, major advances have been made in our understanding of key pathways that control tumor progression. This has led to the development of new anticancer agents that have the ability to block the activity of proteins involved in neoplastic cell development and proliferation. Targeted Therapies in Oncology, Second Edition provides a concise timely panorama of existing targeted therapies and progress into future anticancer treatments.

These therapies notably include:

  • Targeted agents of immune checkpoints

  • Signal-transduction inhibitors

  • Antiangiogenic agents

  • Vascular-disrupting agents

  • Apoptosis modulators

  • Stem cell inhibitors

  • Tumor profiling for drug development

The book emphasizes the biology behind this new class of drugs as well as the clinical achievements obtained. The contributors to this volume stand at the cutting edge of cancer research and treatment around the world.


We provide complimentary e-inspection copies of primary textbooks to instructors considering our books for course adoption.

Request an
e-inspection copy

Share this Title